@article {44011,
	title = {Repurposing Ivacaftor for treatment of staphylococcus aureus infections},
	journal = {International Journal of Antimicrobial Agents},
	volume = {50},
	year = {2017},
	month = {SEP},
	pages = {389-392},
	type = {Journal Article},
	abstract = {<p>Drug repurposing of non-antimicrobials is a novel method to augment a seriously depleted drug pipeline for targeting drug{\textendash}resistant pathogens. This article highlights the potent antimicrobial activity of Ivacaftor against Staphylococcus aureus, including vancomycin{\textendash} and other multidrug{\textendash}resistant strains. The potent activity of Ivacaftor in vivo is also demonstrated in a murine neutropenic thigh infection model. Taken together, these results support the potential of Ivacaftor as an antimicrobial agent for the treatment of staphylococcal infections. {\textcopyright} 2017 Elsevier B.V. and International Society of Chemotherapy</p>},
	doi = {10.1016/j.ijantimicag.2017.03.020},
	author = {Thakare, R. and Das, S. and Vasudevan, N. and Jachak, G.R. and Reddy, D.S. and Dasgupta, A. and Chopra, S.},
	editor = {Singh, A. K.}
}
